Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports By Reuters Read more
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy By Reuters Read more
Denmark’s Novo Nordisk expects 27% sales surge this year but faces price pressure for weight loss drug Wegovy amid Eli Lilly competition Read more
Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings By Investing.com Read more